 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper   
127th MAINE LEGISLATURE  
 
SECOND REGULAR SESSION -2016  
 
Legislative Document  No. 1648  
S.P. 674  In Senate, March 10, 2016  
 
 
An Act To Amend the Laws Governing the Controlled Substances 
Prescription Monitoring Program and To Review Limits on the 
Prescription of Controlled Substances  
 
(AFTER DEADLINE)  
 
 
 
Approved for introduction by a majority of the Legislative Council pursuant to Joint Rule 
205. 
Reference to the Committee on Health and Human Services suggested and orde red printed.  
 
 
  
 HEATHER J.R. PRIEST  
 Secretary of the Senate  
 
Presented by Senator KATZ of Kennebec.  
Cosponsored by Representative VACHON of Scarborough and  
Senator: HASKELL of Cumberland, Representatives: Speaker EVES of North Berwick, 
GATTINE of Westbrook, MALABY of Hancock, SANBORN of Gorham, TUELL of East 
Machias.  
 
 

 
 Page 1 - 127LR2718(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA §7250, sub -§4, ¶H, as enacted by PL 2011, c. 218, §3, is 2 
amended to read:  3 
H.  Another state or a Canadian province  pursuant to subsection 4 -A. 4 
Sec. 2.  22 MRSA §7250, sub -§4-A, as amended by PL 2011, c. 657, Pt. AA, 5 
§69, is further amended to read:  6 
4-A.  Information sharing with other states and Canadian provinces.   The 7 
department may provide prescription monitoring information to and receive prescription 8 
monitoring information f rom another state or a Canadian province  that has prescription 9 
monitoring information provisions consistent with this chapter and has entered into a 10 
prescription monitoring information sharing agreement with the department.  The 11 
department may enter into a  prescription monitoring information sharing agreement with 12 
another state or a Canadian province  to establish the terms and conditions of prescription 13 
monitoring information sharing and interoperability of information systems and to carry 14 
out the purposes of this subsection.  For purposes of this subsection, "another state" 15 
means any state other than Maine and any territory or possession of the United States , but 16 
does not include a foreign country . 17 
Sec. 3.  Licensing boards to amend rules to require prescri bers and 18 
dispensers to use the Controlled Substances Prescription Monitoring 19 
Program.  The Board of Licensure in Medicine, Board of Osteopathic Licensure, Board 20 
of Dental Examiners, State Board of Nursing, Board of Licensure of Podiatric Medicine, 21 
Maine Bo ard of Pharmacy and State Board of Veterinary Medicine shall examine the 22 
circumstances in which prescribers and dispensers of controlled substances should be 23 
required to check the prescription monitoring information maintained by the Controlled 24 
Substances Prescription Monitoring Program in the Maine Revised Statutes, Title 22, 25 
chapter 1603.  No later than January 1, 2017, the Board of Licensure in Medicine, Board 26 
of Osteopathic Licensure, Board of Dental Examiners, State Board of Nursing and Board 27 
of Licens ure of Podiatric Medicine shall amend the joint rule of the boards governing the 28 
use of controlled substances for treatment of pain to specify the circumstances in which 29 
prescribers of controlled substances are required to check the prescription monitoring  30 
information maintained by the Controlled Substances Prescription Monitoring Program.  31 
No later than January 1, 2017, the Maine Board of Pharmacy and State Board of 32 
Veterinary Medicine shall amend their rules to specify the circumstances in which 33 
dispenser s of controlled substances are required to check the prescription monitoring 34 
information maintained by the Controlled Substances Prescription Monitoring Program.  35 
Sec. 4.  Licensing boards to review MaineCare prescribing limits.  No later 36 
than January 1, 20 17, the Board of Licensure in Medicine, Board of Osteopathic 37 
Licensure, Board of Dental Examiners, State Board of Nursing and Board of Licensure of 38 
Podiatric Medicine shall review the limits on controlled substances applied by the 39 
MaineCare program on the effective date of this Act and determine whether these limits 40 
should apply to all patients and, if so, how these limits may be implemented.  If these 41 
limits are found to be necessary and feasible, the boards shall amend their rules or a joint 42 
 
 Page 2 - 127LR2718(01) -1 
 rule to imple ment these limits, but the amended rules or joint rule may not be effective 1 
prior to July 1, 2017.  2 
Sec. 5.  Department of Health and Human Services to amend rules to 3 
require registration of pharmacists.  The Department of Health and Human 4 
Services shall am end its rules governing the Controlled Substances Prescription 5 
Monitoring Program no later than January 1, 2017 to require the registration of 6 
pharmacists as data requesters.  7 
SUMMARY  8 
This bill directs the licensing boards regulating prescribers and dispens ers of 9 
controlled substances to engage in rulemaking regarding required use of the Controlled 10 
Substances Prescription Monitoring Program and to review the possibility of establishing 11 
prescribing limits.  It requires pharmacists to register to use the progr am and allows the 12 
Department of Health and Human Services to provide prescription monitoring 13 
information to and receive prescription monitoring information from a Canadian 14 
province.  15 
 
